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Prarthi Patel, BS, G. Anthony Fidacaro Jr, MD, Gerard Carroll, MD, Holly Bartimus, MD, Krystal Hunter, MBA, and Rick Hong, MD 
Study Aims
Background: Patients receiving naloxone for suspected opioid 
over- dose in the prehospital setting are typically transported to the 
emergency department (ED) for further evaluation, regardless of 
Glasgow Coma Scale (GCS).
Objective: The objective of our study is to determine whether 
patients with GCS >= 14 after receiving prehospital naloxone 
received additional doses of naloxone and medical inter- ventions in 
the ED compared with those with GCS <14 after prehospital 
naloxone. 
Conclusion
Patients with GCS score >= 14 after administration of prehospital 
naloxone are less likely to receive additional naloxone doses and 
medical interventions in the ED compared with those with a GCS 
score <14 after prehospital naloxone and may present an 
invaluable opportunity for the ED to initiate an addiction 
treatment program for patients with nonfatal overdose. 
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Results
• 473 patient encounters were reviewed. 
• Most common route of prehospital naloxone administration was 
intranasal (68%). 
• Nearly two-thirds (n=473) of patients had GCS >= 14 upon ED 
arrival.
• Repeat naloxone was administered to 3.5% (n = 314) of patients 
with GCS >= 14 versus 14.6% (n =159) of patients with GCS 
<14. 
• ED interventions, such as airway maneuvers, laboratory and 
radiology testing, and cardiac monitoring, were less common 
among patients who had improved GCS of 14 or higher (n =
314).
• There were 8 deaths among patients with GCS <14 (n = 159) and 
no deaths among patients with GCS > = 14 (n = 314). 
Introduction
According to the Centers for Disease Control and Prevention the Opioid use disorder has been 
described as a national epidemic. Naloxone, an opioid antagonist, reverses opioid overdose when given 
in a timely manner. This study is to analyze whether varying levels of GCS has an impact on if a patient 
is administered additional doses and medical interventions in the ED.
Methods
• A retrospective observational study of EMS and ED medical 
records was used to collect data. The Cooper University Hospital 
Institutional Review Board approved our study. 
• Included patients >=18 years old treated with naloxone and 
transported by an inner-city hospital-based Emergency Medical 
Services (EMS) to its affiliated ED from January 2, 2016 to 
December 31, 2016.
• Categorical data are presented as proportions and tested for 
significance using chi-square or Fisher exact tests.
• The main outcome measures were repeat doses of naloxone and 
ED interventions. 
Discussion
• Over one-third of patients in both comparison groups were given 
multiple doses of naloxone, with a majority of the first dose being 
given IN and subsequent doses being given IV. 
• A large proportion of patients who present to the ED with GCS >= 
14 after receiving prehospital naloxone do not require repeat 
naloxone dosing throughout the ED evaluation. 
• Patients with GCS >= 14 before ED evaluation are less likely to 
receive ED interventions when compared with patients with GCS 
<14. 
• The average LOS for patients with GCS >= 14 compared with GCS 
<14 was significantly shorter and the average LOS for patients with 
GCS <14 who were admitted versus who were not admitted was 
also significantly longer (664.5 vs 311 minutes).
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